Investor Overview

Corporate Profile

Accuray develops, manufactures and sells radiation oncology systems that make cancer treatments shorter, safer, smarter and more effective. Accuray provides treatment delivery technologies that set the industry standard for precision and cover the full range of radiation therapy and radiosurgery treatments, as well as fully integrated software solutions that drive faster, smarter treatment planning.
Press Releases
  • August 13, 2020 at 4:02 PM EDT
    SUNNYVALE, Calif. , Aug. 13, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2020 .     Q4 Fiscal 2020 and Recent Operating Highlights Gross orders of $94.3 million , including 8 orders from China Net
  • July 22, 2020 at 4:05 PM EDT
    SUNNYVALE, Calif. , July 22, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Anne B. Le Grand to the company's Board of Directors, effective as of July 16, 2020 . In addition, she will serve on the Board's Nominating and Corporate Governance Committee .
Annual Reports
Filing date Form
10-K
10-K